BrightGene Bio-Medical to host Q3 2025 earnings call

BrightGene Bio-Medical Technology (Suzhou) Co., Ltd. will hold its 2025 third-quarter earnings conference on Tuesday, December 2, 2025, from 13:00 to 14:00. The online conference, hosted via the Shanghai Stock Exchange Roadshow Center, aims to provide investors with a comprehensive understanding of the company’s operating results and financial condition for the third quarter of 2025.

The event follows the release of the company's Q3 2025 report on October 31, 2025. Participants can submit questions in advance between November 25, 2025, and December 1, 2025, at 16:00, either through the "Question Pre-collection" section on the SSE Roadshow Center website or by emailing IR@bright-gene.com.

Key company representatives expected to attend include chairman and general manager Yuan Jiandong, cfo Zou Yuanlai, independent director Xu Dongdong, and board secretary Ding Nan. A recording and summary of the conference will be available on the SSE Roadshow Center website afterward.